The recently approved vaccine, made by Moderna, targets two different coronavirus variants – the original virus from 2020 and the Omicron variant
This is a companion discussion topic for the original entry at https://www.sciencemediacentre.co.nz/2022/08/17/omicron-specific-boosters-expert-reaction/